Alto Ingredients Reports Third Quarter 2021 Results

Rhea-AI Summary

Alto Ingredients reported a third quarter net loss of $3.5 million for the period ending September 30, 2021, despite achieving positive adjusted EBITDA of $3.0 million. Net sales increased to $306 million, a significant rise from $204.7 million year-over-year, attributed to higher production and pricing. The company sold its Stockton, CA facility, retiring $150 million in term debt. However, gross loss of $3.4 million was noted due to increased costs. The company anticipates an annual EBITDA increase of $18.5 million starting in 2022.

Positive

• Net sales grew to $306 million, up from $204.7 million YoY.
• Sold Stockton facility, retiring $150 million in debt.
• Expected annual EBITDA increase of $18.5 million starting 2022.

Negative

• Third quarter net loss of $3.5 million.
• Gross loss of $3.4 million compared to prior year's gross profit of $20.9 million.
• Adjusted EBITDA declined to $3.0 million from $34.1 million YoY.

• Third Quarter Net Loss of $3.5 million and Positive Adjusted EBITDA of $3.0 million
• Subsequent to Quarter-End, the Company Sold its Stockton, CA Facility
• Company is Now Term Debt Free
  

SACRAMENTO, Calif., Nov. 09, 2021 (GLOBE NEWSWIRE) -- Alto Ingredients, Inc. (NASDAQ: ALTO), a leading producer of specialty alcohols and essential ingredients, reported its financial results for the third quarter ended September 30, 2021.

“In the third quarter we made significant progress in advancing our strategic initiatives, expanding our essential ingredients business and improving our infrastructure,” said Mike Kandris, CEO of Alto Ingredients. “We launched an enhanced protein project through the installation of Harvesting Technology’s patented CoPromax™ system at our Magic Valley, Idaho facility. At our Pekin campus, we made significant progress on a number of initiatives. We completed our yeast expansion project and will have our upgraded feed dryers operational by year end. We also finished expanding the capacity of our corn oil production and significantly improved the efficiency and reliability of our Pekin wet mill to further support customer demand long term. We are also working on extending the certifications we obtained at the end of 2020 from our ICP distillery to our Pekin wet mill. We expect to complete this effort by the end of this year and by doing so, provide unique redundancy across the entire Pekin campus and further surety of quality supply to our customers.

“Subsequent to quarter end, on November 8th we announced the sale of our Stockton, California fuel-grade ethanol facility, completing the realignment of our fuel-grade ethanol operations we began 21 months ago. The proceeds from these asset sales were integral to our strategy and contributed to the retirement of approximately $150 million dollars in term debt over this same period – thus achieving our stated goal to prepay this expensive and restrictive term debt by year end 2021.

“We have completed or are on track to complete this year a number of projects that will increase our annual EBITDA by $18.5 million starting in 2022. Long-term, we will continue to build on our specialty alcohols and essential ingredients business, focusing our resources on driving profitable growth and progressing our strategic initiatives.”

“Net sales were $306 million, up approximately $100 million from the prior year’s quarter due to an increase in both gallons produced and the average price per gallon sold,” stated Bryon McGregor, CFO of Alto Ingredients. “Last year’s specialty alcohol sales uniquely benefited from a spike in sanitizer and disinfectant demand from COVID-19. When examining costs and bottom line comparatively, the planned outage of our wet mill, as expected, materially impacted our total revenues and cost of goods sold, driving the gross loss in this year’s quarter compared to last year’s gross profit.

“Going forward, while we anticipate continued volatility in sanitizer and disinfectant demand over foreseeable future, we expect a more stable, new demand-supply equilibrium will ultimately be achieved as COVID-19 impacts dissipate. We also expect an increase in fixed-price contracted specialty alcohol sales and growing specially alcohol exports. Our upgraded wet mill facility with significantly improved efficiency and reliability will enable us to further support customer demand long term.”

Financial Results for the Three Months Ended September 30, 2021 Compared to 2020

• Net sales were $305.6 million, compared to $204.7 million.
• Cost of goods sold was $309.0 million, compared to $183.8 million.  
• Gross loss was $3.4 million, compared to a gross profit of $20.9 million.
• Selling, general and administrative expenses were $5.5 million, compared to $6.4 million.
• Operating loss was $8.9 million, compared to operating income of $26.3 million.
• Net loss available to common stockholders was $3.5 million, or $0.05 per share, compared net income of $14.9 million, or $0.24 per diluted share.
• Adjusted EBITDA was $3.0 million, compared to $34.1 million.
• Cash and cash equivalents were $36.0 million at September 30, 2021, compared to $47.7 million at December 31, 2020.
• On November 8, 2021, the company announced its sale of its fuel-grade ethanol production facility in Stockton, California for $24.0 million in cash.

Financial Results for the Nine Months Ended September 30, 2021 Compared to 2020

• Net sales were $822.4 million, compared to $728.2 million.
• Cost of goods sold was $796.7 million, compared to $689.0 million.  
• Gross profit was $25.7 million, compared to $39.2 million.
• Selling, general and administrative expenses were $19.8 million, compared to $25.2 million.
• Operating income was $2.8 million, compared to $25.7 million.
• Net income available to common stockholders was $9.0 million, or $0.12 per diluted share, compared to $4.1 million, or $0.07 per diluted share.
• Adjusted EBITDA was $33.4 million, compared to $50.6 million.
  

Third Quarter 2021 Results Conference Call
Management will host a conference call at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time on Tuesday, November 9, 2021, and will deliver prepared remarks via webcast followed by a question-and-answer session.

The webcast for the call can be accessed from Alto Ingredients’ website at www.altoingredients.com. Alternatively, you may dial the following number up to ten minutes prior to the scheduled conference call time: (877) 847-6066. International callers should dial 00-1 (970) 315-0267. The pass code will be 3778898. If you are unable to participate in the live call, the webcast will be archived for replay on Alto Ingredients’ website for one year. In addition, a telephonic replay will be available at 8:00 p.m. Eastern Time on Tuesday, November 9, 2021, through 8:00 p.m. Eastern Time on Tuesday, November 16, 2021. To access the replay, please dial (855) 859-2056. International callers should dial 00-1 (404) 537-3406. The pass code will be 3778898.

Use of Non-GAAP Measures

Management believes that certain financial measures not in accordance with generally accepted accounting principles ("GAAP") are useful measures of operations. The company defines Adjusted EBITDA as unaudited net income (loss) attributed to Alto Ingredients, Inc. before interest expense, interest income, provision (benefit) for income taxes, asset impairments, loss on extinguishment of debt, purchase accounting adjustments, fair value adjustments, and depreciation and amortization expense. A table is provided at the end of this release that provides a reconciliation of Adjusted EBITDA to its most directly comparable GAAP measure, net income (loss) attributed to Alto Ingredients, Inc. Management provides this non-GAAP measure so that investors will have the same financial information that management uses, which may assist investors in properly assessing the company's performance on a period-over-period basis. Adjusted EBITDA is not a measure of financial performance under GAAP and should not be considered as an alternative to net income (loss) attributed to Alto Ingredients, Inc. or any other measure of performance under GAAP, or to cash flows from operating, investing or financing activities as an indicator of cash flows or as a measure of liquidity. Adjusted EBITDA has limitations as an analytical tool and you should not consider this measure in isolation or as a substitute for analysis of the company's results as reported under GAAP.

About Alto Ingredients, Inc.
Alto Ingredients, Inc. (ALTO), formerly known as Pacific Ethanol, Inc., is a leading producer of specialty alcohols and essential ingredients. The company is focused on products for four key markets: Health, Home & Beauty; Food & Beverage; Essential Ingredients; and Renewable Fuels. The company’s customers include major food and beverage companies and consumer products companies. For more information please visit www.altoingredients.com.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995
Statements and information contained in this communication that refer to or include Alto Ingredients’ estimated or anticipated future results or other non-historical expressions of fact are forward-looking statements that reflect Alto Ingredients’ current perspective of existing trends and information as of the date of the communication. Forward looking statements generally will be accompanied by words such as “anticipate,” “believe,” “plan,” “could,” “should,” “estimate,” “expect,” “forecast,” “outlook,” “guidance,” “intend,” “may,” “might,” “will,” “possible,” “potential,” “predict,” “project,” or other similar words, phrases or expressions. Such forward-looking statements include, but are not limited to, statements concerning the timing and effects of Alto Ingredients’ strategic initiatives, including its plant improvement projects and extended certifications; the expected effect on annual EBITDA of Alto Ingredients’ plant improvement projects; and Alto Ingredients’ other plans, objectives, expectations and intentions. It is important to note that Alto Ingredients’ plans, objectives, expectations and intentions are not predictions of actual performance. Actual results may differ materially from Alto Ingredients’ current expectations depending upon a number of factors affecting Alto Ingredients’ business. These factors include, among others, adverse economic and market conditions, including for specialty alcohols and essential ingredients; export conditions and international demand for the company’s products; fluctuations in the price of and demand for oil and gasoline; raw material costs, including production input costs, such as corn and natural gas; Alto Ingredients’ ability to successfully and timely execute on its plant improvement projects; and the effects – both positive and negative – of the coronavirus pandemic and its resurgence or abatement. These factors also include, among others, the inherent uncertainty associated with financial and other projections; the anticipated size of the markets and continued demand for Alto Ingredients’ products; the impact of competitive products and pricing; the risks and uncertainties normally incident to the specialty alcohol production and marketing industries; changes in generally accepted accounting principles; successful compliance with governmental regulations applicable to Alto Ingredients’ distilleries, products and/or businesses; changes in laws, regulations and governmental policies; the loss of key senior management or staff; and other events, factors and risks previously and from time to time disclosed in Alto Ingredients’ filings with the Securities and Exchange Commission including, specifically, those factors set forth in the “Risk Factors” section contained in Alto Ingredients’ Quarterly Report on Form 10-Q filed with the Securities and Exchange Commission on August 10, 2021.

Media Contact:                 
Bryon McGregor, Alto Ingredients, Inc., 916-403-2768, mediarelations@altoingredients.com

Company IR Contact:                 
Michael Kramer, Alto Ingredients, Inc., 916-403-2755, Investorrelations@altoingredients.com

IR Agency Contact:
Moriah Shilton, LHA Investor Relations, 415-433-3777, Investorrelations@altoingredients.com

 

ALTO INGREDIENTS, INC.
CONSOLIDATED STATEMENTS OF OPERATIONS
(unaudited, in thousands, except per share data)

	Three Months Ended September 30,								Nine Months Ended September 30,
	2021				2020				2021				2020
Net sales	$	305,556			$	204,727			$	822,400			$	728,205
Cost of goods sold		308,955				183,797				796,729				688,983
Gross profit (loss)		(3,399	)			20,930				25,671				39,222
Selling, general and administrative expenses		(5,533	)			(6,404	)			(19,777	)			(25,245	)
Asset impairments		—				—				(3,100	)			—
Gain on litigation settlement		—				11,750				—				11,750
Income (loss) from operations		(8,932	)			26,276				2,794				25,727
Interest expense, net		(429	)			(4,199	)			(3,359	)			(14,153	)
Income from loan forgiveness		5,973				—				9,860				—
Fair value adjustments		—				(6,856	)			—				(7,497	)
Other income (expense), net		256				(6	)			641				(1,164	)
Income (loss) before benefit for income taxes		(3,132	)			15,215				9,936				2,913
Benefit for income taxes		—				—				—				—
Consolidated net income (loss)		(3,132	)			15,215				9,936				2,913
Net loss attributed to noncontrolling interests		—				—				—				2,166
Net income (loss) attributed to Alto Ingredients, Inc.	$	(3,132	)		$	15,215			$	9,936			$	5,079
Preferred stock dividends	$	(319	)		$	(319	)		$	(946	)		$	(949	)
Net income (loss) available to common stockholders	$	(3,451	)		$	14,896			$	8,990			$	4,130
Net income (loss) per share, basic	$	(0.05	)		$	0.25			$	0.13			$	0.07
Net income (loss) per share, diluted	$	(0.05	)		$	0.24			$	0.12			$	0.07
Weighted-average shares outstanding, basic		71,383				58,503				71,002				55,620
Weighted-average shares outstanding, diluted		71,383				61,699				72,260				57,958

ALTO INGREDIENTS, INC.
CONSOLIDATED BALANCE SHEETS
(unaudited, in thousands, except par value)

	September 30, 2021			December 31, 2020
ASSETS
Current Assets:
Cash and cash equivalents	$	36,029		$	47,667
Accounts receivable, net		78,424			43,491
Inventories		58,117			37,925
Prepaid inventory		5,480			891
Derivative instruments		12,977			17,149
Assets held-for-sale		30,158			58,295
Other current assets		5,413			8,628
Total current assets		226,598			214,046
Property and equipment, net		224,319			229,486
Other Assets:
Right of use operating lease assets, net		12,715			11,046
Notes receivable		12,423			14,337
Intangible assets		2,678			2,678
Other assets		4,671			5,225
Total other assets		32,487			33,286
Total Assets	$	483,404		$	476,818

ALTO INGREDIENTS, INC.
CONSOLIDATED BALANCE SHEETS (CONTINUED)
(unaudited, in thousands, except par value)

	September 30, 2021				December 31, 2020
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current Liabilities:
Accounts payable – trade	$	28,387			$	13,047
Accrued liabilities		15,455				11,101
Current portion – operating leases		3,216				2,180
Current portion – long-term debt		17,687				25,533
Derivative instruments		2,735				—
Liabilities held-for-sale		10,500				19,542
Other current liabilities		6,468				15,524
Total current liabilities		84,448				86,927
Long-term debt, net of current portion		70,621				71,807
Operating leases, net of current portion		9,365				8,715
Other liabilities		13,774				13,134
Total Liabilities		178,208				180,583
Stockholders’ Equity:
Alto Ingredients, Inc. Stockholders’ Equity:
Preferred stock, $0.001 par value; 10,000 shares authorized; Series A: 0 shares issued and outstanding as of September 30, 2021 and December 31, 2020 Series B: 927 shares issued and outstanding as of September 30, 2021 and December 31, 2020		1				1
Common stock, $0.001 par value; 300,000 shares authorized; 72,800 and 72,487 shares issued and outstanding as of September 30, 2021 and December 31, 2020, respectively		73				72
Non-voting common stock, $0.001 par value; 3,553 shares authorized; 1 share issued and outstanding as of September 30, 2021 and December 31, 2020		—				—
Additional paid-in capital		1,036,608				1,036,638
Accumulated other comprehensive loss		(3,878	)			(3,878	)
Accumulated deficit		(727,608	)			(736,598	)
Total Stockholders’ Equity		305,196				296,235
Total Liabilities and Stockholders’ Equity	$	483,404			$	476,818

Reconciliation of Adjusted EBITDA to Net Income (Loss)

	Three Months Ended September 30,								Nine Months Ended September 30,
(in thousands) (unaudited)	2021				2020				2021				2020
Net income (loss) attributed to Alto Ingredients, Inc.	$	(3,132	)		$	15,215			$	9,936			$	5,079
Adjustments:
Interest expense		429				4,199				3,359				14,153
Interest income		(183	)			(196	)			(553	)			(368	)
Asset impairments		—				—				3,100				—
Fair value adjustments		—				6,856				—				7,497
Benefit for income taxes		—				—				—				—
Depreciation and amortization expense*		5,851				8,049				17,520				24,254
Total adjustments		6,097				18,908				23,426				45,536
Adjusted EBITDA	$	2,965			$	34,123			$	33,362			$	50,615

* Adjusted for noncontrolling interests.

Commodity Price Performance

	Three Months Ended September 30,								Nine Months Ended September 30,
(unaudited)	2021				2020				2021						2020
Fuel-grade ethanol production gallons sold (in millions)		38.3				21.9				118.6						148.0
Specialty alcohol production gallons sold (in millions)		19.7				21.6				63.1						74.9
Third party fuel-grade ethanol gallons sold (in millions)		67.2				76.7				180.5						213.0
Total gallons sold (in millions)		125.2				120.2				362.2						435.9
Total gallons produced (in millions)		60.6				45.2				182.2						209.1
Production capacity utilization		59	%			40	%			57			%			54			%
Average sales price per gallon	$	2.47			$	1.71			$	2.27					$	1.60
Average CBOT ethanol price per gallon	$	2.25			$	1.27			$	2.08					$	1.20
Corn cost – CBOT equivalent	$	6.09			$	3.29			$	5.71					$	3.49
Average basis		0.89				0.22				0.53						0.29
Delivered cost of corn	$	6.98			$	3.51			$	6.24					$	3.78
Total essential ingredients tons sold (in thousands)		305.6				255.5				886.5						1,177.5
Co-product return % (1)		29.5	%			50.2	%			33.8			%			44.6		%

⁽¹⁾ Co-product revenue as a percentage of delivered cost of corn.

Segment Financials

			Three Months Ended September 30,																			Nine Months Ended September 30,
			2021									2020										2021										2020
Net sales
Kinergy marketing and distribution:
Alcohol sales, gross			$	112,391								$	84,001									$	255,702									$	212,625
Alcohol sales, net				505									382										1,489										1,117
Intersegment sales				2,415									1,598										7,277										7,751
Total marketing and distribution sales				115,311									85,981										264,468										221,493
Pekin Campus production, recorded as gross:
Alcohol sales			$	114,587								$	77,075									$	341,967									$	255,737
Essential ingredient sales				46,016									27,619										140,670										101,123
Intersegment sales				293									197										920										877
Total Pekin Campus sales				160,896									104,891										483,557										357,737
Other production, recorded as gross:
Alcohol sales			$	25,190								$	11,765									$	63,311									$	120,797
Essential ingredient sales				6,867									3,885										19,261										36,806
Intersegment sales				259									420										896										1,121
Total Other production sales				32,316									16,070										83,468										158,724
Intersegment eliminations				(2,967						)			(2,215							)			(9,093							)			(9,749								)
Net sales as reported			$	305,556								$	204,727									$	822,400									$	728,205
Cost of goods sold:
Kinergy marketing and distribution			$	105,902								$	84,589									$	245,606									$	210,827
Pekin Campus production				169,721									80,280										468,972										302,120
Other production				35,613									20,718										87,055										181,382
Intersegment eliminations				(2,281						)			(1,790							)			(4,904							)			(5,346								)
Cost of goods sold as reported			$	308,955								$	183,797									$	796,729									$	688,983
Gross profit (loss):
Kinergy marketing and distribution			$	9,409								$	1,392									$	18,862									$	10,666
Pekin Campus production				(8,825						)			24,611										14,585										55,617
Other production				(3,297						)			(4,648							)			(3,587							)			(22,658								)
Intersegment eliminations				(686						)			(425							)			(4,189							)			(4,403								)
Gross profit (loss)			$	(3,399						)		$	20,930									$	25,671									$	39,222

 

FAQ

What was Alto Ingredients' net loss for the third quarter of 2021?

Alto Ingredients reported a net loss of $3.5 million for the third quarter of 2021.

How much did Alto Ingredients' net sales increase in Q3 2021?

Net sales for Alto Ingredients increased to $306 million in Q3 2021, up from $204.7 million in the same quarter of 2020.

What was the adjusted EBITDA for Alto Ingredients in Q3 2021?

Alto Ingredients reported an adjusted EBITDA of $3.0 million for the third quarter of 2021.

What actions did Alto Ingredients take regarding its debt in Q3 2021?

Alto Ingredients retired approximately $150 million in term debt following the sale of its Stockton facility.

What is expected to happen with Alto Ingredients' EBITDA starting in 2022?

The company expects an increase in annual EBITDA by $18.5 million starting in 2022.